The grumbling concerns and problems with dabigatran, including haemorrhagic complications, lack of a tidy reversal agent and widespread off-label use and associated problems are well summarised in Ryan Radecki’s (of emlitofnote.com) opinion article in Annals of IM here.
- RT @weterpasson: Thread. Northern Ireland is completely banjaxed, and the DUP going into Government with the Tories is only going to make i… 2 months ago
- RT @MJA_Editor: There should be no children in offshore detention. None. Detention harms health, evidence is not in dispute. Our collective… 3 months ago
- @GeoffCouser @abcnewsTas if it's been undiscovered until now it'd be hard to justify panicking! Seen this? theguardian.com/environment/20… 4 months ago